Tom Dormans

4.2k citations

31 papers · 1.2k indexed · h-index 15

Cardiology and Cardiovascular Medicine top 5%
Pulmonary and Respiratory Medicine top 10%
Critical Care and Intensive Care Medicine top 1%
Epidemiology
Infectious Diseases top 10%

Co-authors: P. G. G. Gerlag Paul Smits Frans G. M. Rüssel J. J. M. Van Meyel Yuen Tan Peter Pickkers Anne Marie G. A. de Smet Mirelle Koeman
Topics: COVID-19 Clinical Research Studies (6 papers)Heart Failure Treatment and Management (5 papers)Nosocomial Infections in ICU (5 papers)
Cited by: Critical Care and Intensive Care Medicine Cardiology and Cardiovascular Medicine Nephrology
Journals: CirculationSHILAP Revista de lepidopterologíaJournal of the American College of Cardiology
Partner nations: Netherlands United States Switzerland

In The Last Decade

Tom Dormans

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by Tom Dormans

Since Specialization

Citations

This map shows the geographic impact of Tom Dormans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Dormans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Dormans more than expected).

Fields of papers citing papers by Tom Dormans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Dormans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Dormans. The network helps show where Tom Dormans may publish in the future.

Co-authorship network of co-authors of Tom Dormans

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Dormans. A scholar is included among the top collaborators of Tom Dormans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Dormans. Tom Dormans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted, Condensed Lung Ultrasound Training Program for Image Interpretation: A Prospective Multicenter Observational Study in Intensive Care Unit Professionals 2025 ·Ultrasound in Medicine & Biology ·(unknown),(unknown),(unknown),R. J. Mulder,Sylvia den Boer,Laura A. Cox,Tom Dormans,(unknown),Harm J. Scholten,Marcus J. Schultz,Marry R. Smit,Lieuwe D. J. Bos,Frederique Paulus,Pieter R. Tuinman	2
2	Emergency Department Triage, Transfer Times, and Hospital Mortality of Patients Admitted to the ICU: A Retrospective Replication and Continuation Study* 2024 ·Critical Care Medicine ·(unknown),(unknown),Fabian Termorshuizen,Wim J. R. Rietdijk,(unknown),Berry I. Cleffken,Tom Dormans,Jelle L. Epker,Lida Feyz,(unknown),(unknown),Evert de Jonge,(unknown),(unknown),Özcan Sir,Peter E. Spronk,Wytze J. Vermeijden,Peter Van de Vliet,Nicolette F. de Keizer,Corstiaan A. den Uil	3
3	Late tuberculosis reactivation after severe COVID-19 2024 ·European Journal of Case Reports in Internal Medicine ·Tom Dormans,(unknown),F S Stals	3
4	Impact of reduced antibiotic treatment duration on antimicrobial resistance in critically ill patients in the randomized controlled SAPS-trial 2023 ·Frontiers in Medicine ·Arezoo Shajiei,(unknown),Christian F. Luz,(unknown),Hermie J. M. Harmsen,Piet Vos,(unknown),Bert G. Loef,Auke C. Reidinga,(unknown),(unknown),Tom Dormans,Martine Otten,(unknown),Albertus Beishuizen,Dylan W. de Lange,Evelien de Jong,Maarten W. Nijsten	1
5	Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the Netherlands 2023 ·BMJ Open ·(unknown),R.W.M.M. Jansen,Joris R. de Groot,(unknown),Martin E W Hemels,Renée A. Douma,(unknown),Kees Brinkman,Hazra S. Moeniralam,Martijn D. de Kruif,Tom Dormans,Brent Appelman,Auke C. Reidinga,(unknown),(unknown),(unknown),Martijn Beudel,Suat Şimşek	3
6	What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitals 2023 ·BMJ Open ·(unknown),Marije ten Wolde,Martijn Beudel,Rik Olde Engberink,Brent Appelman,(unknown),(unknown),(unknown),Suat Şimşek,(unknown),Joop P. van den Bergh,Caroline E. Wyers,Martijn D. de Kruif,Tom Dormans,Hazra S. Moeniralam,(unknown),Kees Brinkman,Renée Douma	2
7	Pulmonary embolism in hospitalized COVID-19 patients: Short- and long-term clinical outcomes 2023 ·SHILAP Revista de lepidopterología ·(unknown),Jacqueline Buijs,Jasenko Krdzalic,Martijn D. de Kruif,Guy J.M. Mostard,Hugo Ten Cate,Tom Dormans,Rémy L.M. Mostard,Mathie P.G. Leers,Daan J.L. van Twist	2
8	Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study 2021 ·BMJ Open ·Didier Collard,Nick S. Nurmohamed,Yannick Kaiser,Laurens F. Reeskamp,Tom Dormans,Hazra S. Moeniralam,Suat Şimşek,Renée Douma,(unknown),Auke C. Reidinga,Paul Elbers,Martijn Beudel,Liffert Vogt,Erik S.G. Stroes,Bert‐Jan H. van den Born	28
9	COVID outcome prediction in the emergency department (COPE): using retrospective Dutch hospital data to develop simple and valid models for predicting mortality and need for intensive care unit admission in patients who present at the emergency department with suspected COVID-19 2021 ·BMJ Open ·David van Klaveren,(unknown),Jelmer Alsma,(unknown),(unknown),Marlijn J. A. Kamps,Tom Dormans,(unknown),(unknown),(unknown),(unknown),Hilde R.H. de Geus,Rozemarijn L van Bruchem-Visser,Jelle Miedema,Annelies Verbon,Els van Nood,David M. Kent,Stephanie C. E. Schuit,Hester F. Lingsma	9
10	Early warning scores to assess the probability of critical illness in patients with COVID-19 2021 ·Emergency Medicine Journal ·Lars I. Veldhuis,Milan L. Ridderikhof,Michiel Schinkel,Joop P. van den Bergh,Martijn Beudel,Tom Dormans,Renée Douma,(unknown),(unknown),Karen Koopman,Martijn D. de Kruif,Peter G. Noordzij,Auke C. Reidinga,Wouter de Ruijter,Suat Şimşek,Caroline E. Wyers,Prabath W.B. Nanayakkara,Markus W. Hollmann	15
11	Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study 2020 ·Annals of the Rheumatic Diseases ·Sofía Ramiro,Rémy L.M. Mostard,César Magro‐Checa,(unknown),Tom Dormans,Jacqueline Buijs,Michiel H. M. Gronenschild,Martijn D. de Kruif,E.H.J. van Haren,(unknown),Mathie P.G. Leers,Ralph Peeters,Dennis R. Wong,Robert Landewé	152
12	Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality 2010 ·Intensive Care Medicine ·Guy J. Oudhuis,Dennis C. J. J. Bergmans,Tom Dormans,(unknown),Alfons Kessels,Martin H. Prins,Ellen E. Stobberingh,Annelies Verbon	47
13	Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia 2006 ·American Journal of Respiratory and Critical Care Medicine ·Mirelle Koeman,André van der Ven,Eelko Hak,Hans C. A. Joore,Karin Kaasjager,Anne Marie G. A. de Smet,Graham Ramsay,Tom Dormans,Leon Aarts,(unknown),W N M Hustinx,Ingeborg van der Tweel,Andy M. Hoepelman,Marc J. M. Bonten	267
14	Combination Diuretic Therapy in Severe Congestive Heart Failure 1998 ·Drugs ·Tom Dormans,P. G. G. Gerlag,Frans G. M. Rüssel,Paul Smits	39
15	Administering high-dose furosemide in severe congestive heart failure 1997 ·Cardiology in Review ·Tom Dormans,J. J. M. Van Meyel,P. G. G. Gerlag,(unknown),Frans G. M. Rüssel,Paul Smits	2
16	Pulmonary Lymphangioleiomyomatosis and Cerebrotendinous Xanthomatosis 1997 ·CHEST Journal ·Tom Dormans,Aad Verrips,Johan Bulten,(unknown)	6
17	Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion 1996 ·Journal of the American College of Cardiology ·Tom Dormans,J. J. M. Van Meyel,P. G. G. Gerlag,Yuen Tan,Frans G. M. Rüssel,Paul Smits	219
18	Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. 1996 ·Heart ·Tom Dormans,(unknown),(unknown)	17
19	Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure 1996 ·European Heart Journal ·Tom Dormans,P. G. G. Gerlag	76
20	Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance 1994 ·Journal of Internal Medicine ·J. J. M. Van Meyel,Paul Smits,Tom Dormans,P. G. G. Gerlag,Frans G. M. Rüssel,F. W. J. Gribnau	59

About Tom Dormans

Tom Dormans is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Heart Failure Treatment and Management (5 papers) and Nosocomial Infections in ICU (5 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (294 citations), Cardiology and Cardiovascular Medicine (414 citations) and Nephrology (82 citations). Tom Dormans has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include P. G. G. Gerlag, Paul Smits, Frans G. M. Rüssel, J. J. M. Van Meyel, Yuen Tan, Peter Pickkers, Anne Marie G. A. de Smet, Mirelle Koeman, Graham Ramsay and W N M Hustinx. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact